On March 25, 2020, the FDA held a virtual town hall to present their policy regarding running newly developed & validated SARS-CoV-2 tests prior to Emergency Use Authorization. The presentation is now available for download at https://www.fda.gov/media/136439/download.

Here is their summary slide: